186386-91-4

Basic information

• Product Name: 4-fluoro-1-nitro-2-(2,2,2-trifluoroethoxy)benzene
• Synonyms: 4-fluoro-1-nitro-2-(2,2,2-trifluoroethoxy)benzene
• CAS NO: 186386-91-4
• Molecular Weight: 239.126
• Mol File: 186386-91-4.mol
• Article Data: 11

Chemical Properties

• CAS DataBase Reference: 4-fluoro-1-nitro-2-(2,2,2-trifluoroethoxy)benzene(CAS DataBase Reference)
• NIST Chemistry Reference: 4-fluoro-1-nitro-2-(2,2,2-trifluoroethoxy)benzene(186386-91-4)
• EPA Substance Registry System: 4-fluoro-1-nitro-2-(2,2,2-trifluoroethoxy)benzene(186386-91-4)

Safety Data

• Hazardous Substances Data: 186386-91-4(Hazardous Substances Data)

Upstream product

• 75-89-8 2,2,2-trifluoroethanol 
• 446-35-5 2,4-Difluoronitrobenzene 
• 446-36-6 5-fluoro-2-nitrophenol 
• 6226-25-1 2,2,2-trifluoroethyl trifluoromethanesulphonate 

Downstream Products

• 1301761-77-2 2-fluoro-N-methyl-5-nitro-4-[(2,2,2-trifluoroethyl)oxy]benzenesulfonamide 
• 1094470-95-7 2-fluoro-5-nitro-4-[(2,2,2-trifluoroethyl)oxy]benzenesulfonyl chloride 
• 1301761-78-3 5-amino-2-fluoro-N-methyl-4-[(2,2,2-trifluoroethyl)oxy]benzenesulfonamide 
• 186386-21-0 RS 100975 
• 186388-11-4 1-(3-chloro-propyl)-4-[4-fluoro-2-(2,2,2-trifluoro-ethoxy)-phenyl]-piperazine 
• 186387-05-3 1-[4-fluoro-2-(2,2,2-trifluoroethoxy)-phenyl]-piperazine 
• 1168134-09-5 2-[4-amino-3-bromo-5-(2,2,2-trifluoroethoxy)phenyl]-3-cyclobutylpropionic acid methyl ester 
• 1168134-08-4 2-[4-amino-3-(2,2,2-trifluoroethoxy)phenyl]-3-cyclobutylpropionic acid methyl ester 
• 1168134-07-3 3-cyclobutyl-2-[4-nitro-3-(2,2,2-trifluoroethoxy)phenyl]propionic acid methyl ester 
• 1168134-06-2 [4-nitro-3-(2,2,2-trifluoroethoxy)phenyl]acetic acid methyl ester 
• 1168134-05-1 2-[4-nitro-3-(2,2,2-trifluoroethoxy)phenyl]acetic acid 
• 186386-90-3 4-fluoro-2-(2,2,2-trifluoroethoxy)aniline 

Relevant articles and documents

AMINO PYRIMIDINE COMPOUND FOR INHIBITING PROTEIN TYROSINE KINASE ACTIVITY

An amino pyrimidine compound for inhibiting protein tyrosine kinase activity, a pharmaceutical composition thereof, preparation therefor, and an application thereof. Specifically, an amino pyrimidine compound represented by formula (I), R1, R2, L, Y, R6, W, A, m, and n being defined in the specification, and a pharmaceutically acceptable salt, a stereoisomer, a solvent compound, a hydrate, a polymorphism, a prodrug, or an isotope variant thereof. The compound can be used for treating and/or preventing protein tyrosine kinase-related diseases such as cell proliferative diseases, cancers, and immune diseases.

TETRASUBSTITUTED BENZENES FOR TREATMENT OF EARLY ONSET ALZHEIMER'S DISEASE

Provided are compositions and methods for treating early onset familial Alzheimer's Disease. The compositions and methods can be used for improving one or more aspects of cognitive function in a patient suffering from early onset familial Alzheimer's Dise

COMPOUNDS AND METHODS

Disclosed are compounds having the formula (I): wherein R1, R2, R3, R4, R5, and R6 are as defined herein, and methods of making and using the same.